Exact Mass: 707.3728012
Exact Mass Matches: 707.3728012
Found 83 metabolites which its exact mass value is equals to given mass value 707.3728012
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
PHODA-PS
C34H62NO12P (707.4009421999999)
Bietaserpine
C - Cardiovascular system > C02 - Antihypertensives > C02A - Antiadrenergic agents, centrally acting > C02AA - Rauwolfia alkaloids C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Leucensomycin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents
2-amino-3-[[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C38H62NO9P (707.4161971999999)
2-amino-3-[[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid
C38H62NO9P (707.4161971999999)
(2S)-2-amino-3-[[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
(2S)-2-amino-3-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
(1R,15S,17R,18R,19S,20S)-3-[2-(diethylamino)ethyl]-6,18-dimethoxy-17-[oxo-(3,4,5-trimethoxyphenyl)methoxy]-11,12,14,15,16,17,18,19,20,21-decahydro-1H-yohimban-19-carboxylic acid methyl ester
n-(1-oxo-1-{[(8e,10e,16z)-3,15,24,28-tetrahydroxy-5-methoxy-14,16-dimethyl-22-thia-2,25-diazatricyclo[18.7.1.0²¹,²⁶]octacosa-1(27),2,6,8,10,16,20(28),21(26),24-nonaen-13-yl]oxy}propan-2-yl)cyclohex-1-ene-1-carboximidic acid
C38H49N3O8S (707.3240194000001)
n-(1-oxo-1-{[(6e,8e,10e,16z)-3,15,24,28-tetrahydroxy-5-methoxy-14,16-dimethyl-22-thia-2,25-diazatricyclo[18.7.1.0²¹,²⁶]octacosa-1(27),2,6,8,10,16,20(28),21(26),24-nonaen-13-yl]oxy}propan-2-yl)cyclohex-1-ene-1-carboximidic acid
C38H49N3O8S (707.3240194000001)
2-(2-{[(5r,6r,7s,9s,11r,16r,18s)-19-amino-6-[(3,4-dicarboxybutanoyl)oxy]-11,16,18-trihydroxy-5,9-dimethylnonadecan-7-yl]oxy}-2-oxoethyl)butanedioic acid
(2s)-5-(n,3-dihydroxy-2-{[(2s)-1-hydroxy-5-(n-hydroxyformamido)-2-(methylamino)pentylidene]amino}propanamido)-n-{2-hydroxy-1-[(2-hydroxy-1-{[(3r)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]ethyl}-2-(methylamino)pentanimidic acid
n-(1-oxo-1-{[(4z,10e,12e)-6,18,24,28-tetrahydroxy-16-methoxy-5,7-dimethyl-22-thia-19,25-diazatricyclo[18.7.1.0²¹,²⁶]octacosa-1(27),4,10,12,14,18,20(28),21(26),24-nonaen-8-yl]oxy}propan-2-yl)cyclohex-1-ene-1-carboximidic acid
C38H49N3O8S (707.3240194000001)
2-[2-({18-amino-6-[(3,4-dicarboxybutanoyl)oxy]-10,15,17-trihydroxy-5,8-dimethylnonadecan-7-yl}oxy)-2-oxoethyl]butanedioic acid
2-[2-({19-amino-6-[(3,4-dicarboxybutanoyl)oxy]-11,16,18-trihydroxy-5,9-dimethylnonadecan-7-yl}oxy)-2-oxoethyl]butanedioic acid
5-(n,3-dihydroxy-2-{[1-hydroxy-5-(n-hydroxyformamido)-2-(methylamino)pentylidene]amino}propanamido)-n-[2-hydroxy-1-({2-hydroxy-1-[(1-hydroxy-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]ethyl}-c-hydroxycarbonimidoyl)ethyl]-2-(methylamino)pentanimidic acid
[(2r,3s,4s,5r,6s)-6-{[(2s,3r,4r,5r,6s)-2-{[(10r)-3,10-dihydroxy-8-[(2s)-2-methylbutanoyl]-1,4,8-triazacyclotridec-3-en-1-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2s)-2-methylbutanoate
C32H57N3O14 (707.3840342000001)
(2s)-2-(2-{[(5r,6r,7s,8s,10r,15r,17s,18s)-18-amino-6-{[(3s)-3,4-dicarboxybutanoyl]oxy}-10,15,17-trihydroxy-5,8-dimethylnonadecan-7-yl]oxy}-2-oxoethyl)butanedioic acid
n-(1-oxo-1-{[(4e,10z,12e,14e)-6,18,24,28-tetrahydroxy-16-methoxy-5,7-dimethyl-22-thia-19,25-diazatricyclo[18.7.1.0²¹,²⁶]octacosa-1(27),4,10,12,14,18,20(28),21(26),24-nonaen-8-yl]oxy}propan-2-yl)cyclohex-1-ene-1-carboximidic acid
C38H49N3O8S (707.3240194000001)